Seminar

COVID-19 has brought disease and mortality at levels not seen from a respiratory virus for over 100 years. Immune responses to this virus, which can infect several different tissues, are poorly understood, including the role of antibodies in resolving the infection. In March 2020, we reoriented our lab to develop Enzyme-Linked ImmunoSorbent Assays (ELISA) for human antibody isotypes IgM, IgG and IgA produced in response to the SARS-CoV-2 spike protein. To date we have analyzed samples from 114 patients, including both PCR positive and PCR negative individuals.

Professor Sean Meehan: Cognitive-Motor Interactions and their Implications for Motor Learning-Based Interventions Post-Stroke

The efficacy of skilled practice in promoting beneficial brain reorganization to affect functional recovery has long been appreciated. However, current best practices to stroke rehabilitation are labour intensive and characterized by variable levels of functional recovery.

Dr. Clay Radke
Dr. Clayton (Clay) J. Radke

Professor of Chemical and Biomolecular Engineering and Vision Science at the University California (Berkeley)

Title:Solute Partitioning and Diffusion in Hydrogels: Fundamentals of Drug and Comfort-Agent Delivery

Please join the Centre for Bioengineering and Biotechnology (CBB) and the ݮƵ Institute for Nanotechnology (WIN) on Monday September 30, 2019 for a guest lecture by Dr. Ronald Li, Co-founder and CEO of Novoheart speaking on “Advances of Stem Cell Biotechnology for Development of Bio-artificial Human Heart” [Poster ]

Friday, March 2, 2018 12:30 pm - 2:30 pm EST (GMT -05:00) Monday, April 2, 2018 12:30 pm - 2:30 pm EDT (GMT -04:00) Wednesday, May 2, 2018 12:30 pm - 2:30 pm EDT (GMT -04:00)

UݮƵ Intellectual Property Workshop Series

IP Series Poster
Series Information:

  • TuesdayJanuary 16- 12:30-2:30 pm – IP 101 andCommercialization

  • TuesdayFebruary 13- 12:30-2:00 pm– IPCase Study

  • TuesdayMarch 13- 12:30-2:00pm–Copyright andSoftware

  • TuesdayApril 10- 12:30-2:00pm–Trademarks